Healthcare Stocks
Why Moderna (NASDAQ:MRNA) Stock Jumped 14% to a 52-Week High: Nasdaq-100 (NDX) Return and NIH Cancer Vaccine Push Explained
Index-fund buying and a national cancer vaccine plan landed on the same day, lifting a stock that has already run more than 600% this year
Why Telecom Stocks NASDAQ:TMUS, NYSE:VZ and NYSE:T Fell Up to 13%, and How Big the SpaceX Risk Is
T-Mobile, Verizon and AT&T lost up to 13% in a day. The direction of the risk looks real. The size and speed of the repricing is harder to defend.
SpaceX's (NASDAQ:SPCX) Spectrum Grab Sends America's Big Three Wireless Stocks Tumbling
T-Mobile, Verizon and AT&T post some of their steepest one-day drops in years as investors price in a long-term threat from Starlink Mobile
TSX Weekly Movers: Why Algoma (TSX: ALC), Aritzia (TSX: ATZ) and Six Other Stocks Jumped More Than 10%
Dividend increases, a raised outlook, a takeover bid and an AI-commerce narrative drove the best-performing TSX stocks of the week ended October 9, 2026. Two of the eight moves have no company-specific trigger.
TSX Weekly Movers: Why Algoma (TSX: ALC) and Aritzia (TSX: ATZ) Jumped 20%
Algoma Central (TSX: ALC) stock jumps after special dividend and 48% quarterly dividend increase; Aritzia (TSX: ATZ) shares rally on record second-quarter margin and higher fiscal 2027 revenue outlook
The Wall Street Wrap: October 9, 2026
US stocks rose Friday as software and health care rebounded from Thursday's AI-led selloff, with the Nasdaq up 0.64% and the S&P 500 up 0.59%. T-Mobile, AT&T, and Verizon plunged on SpaceX's spectrum deal while tower operators soared. Delta cut its profit forecast, and Brent held above $104.
Penny Stock Watch: Milestone Jumps While XORTX, bioAffinity Tumble Today
Four small healthcare and biotech penny stocks, all trading under USD 5, made sharp moves today on clinical trial news, a stock offering, and a steep selloff.
FDA Approvals and Trial Results: Teva, Natera, Glaukos Stocks Surge Today
Four healthcare companies delivered major regulatory and clinical news today, covering cancer screening, eye surgery, mental health treatment, and a rare disease drug.
Fall Clinical Dermatology Conference 2026: Lilly, J&J, Arcutis, Alumis, Sagimet Stocks Jump on New Data
Five healthcare companies updated the market this week with fresh psoriasis and acne data from a major dermatology conference, and their stocks reacted fast.
Wall Street Wrap: Pre-Market, October 9, 2026
U.S. stock futures rise as technology stocks rebound from Thursday's selloff sparked by OpenAI's revenue disclosure, while traders weigh Fed hike odds and Treasury yields near 5.24%. SpaceX's spectrum deal lifts tower stocks and hits telecoms, Delta cuts its 2026 outlook on fuel costs, and Humana jumps while Alignment Healthcare plunges on Medicare Star Ratings. Brent slips near $103 after Trump's pledge not to strike Iran before the midterms.
Trending topics
Recent post
The Wall Street Wrap: November 20,...
Wall Street Wrap: Pre-Market, Novem...
Anthropic IPO (NASDAQ:ANT): What Ch...
The Wall Street Wrap: November 19,...